Tufts Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Tufts Medical Center sits in the top decile of US sponsors by registered trial count (#171 of 15,742 sponsors by registered trial count).

169 total trials 18 currently recruiting 111 completed early-phase tilt top decile by trial count

Tufts Medical Center: 169 sponsored US clinical trials, 18 recruiting.

Tufts Medical Center sponsors 169 registered US clinical trials on ClinicalTrials.gov, 18 of them currently recruiting, and 111 completed. 27 of these trials are in Phase 3-4 (later-stage) and 44 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 5 trials.

Top-decile sponsor footprint

Tufts Medical Center ranks in the top decile of sponsors by registered trial count (#171 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

111 of 139 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

169 total, page 3 of 4

TERMINATED

Prospective Functional Outcome Study of the Knee

NCT02079493

COMPLETED NA

Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation

NCT01925534

COMPLETED NA

Vitamin D and Type 2 Diabetes Study

NCT01942694

COMPLETED Phase 2

Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome

NCT01941745

COMPLETED NA

Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.

NCT02309723

COMPLETED Phase 3

Improving Outcomes in Neonatal Abstinence Syndrome

NCT01958476

COMPLETED Phase 1

Does Weight Loss Surgery and Probiotic Supplementation Lead to a "Lean" Gut Microbiota?

NCT01870544

COMPLETED Phase 4

Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation

NCT01789814

TERMINATED Phase 1

Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation

NCT01610999

TERMINATED Phase 1

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

NCT01948271

COMPLETED Phase 2

Eplerenone for Central Serous Chorioretinopathy

NCT01822561

COMPLETED Phase 1

Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors

NCT01806077

TERMINATED Phase 2

Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants

NCT01748045

COMPLETED

Evaluation of a Respiratory Monitor in Surgical Patients With a BMI>35

NCT01825278

COMPLETED Phase 2

Vitamin D for Established Type 2 Diabetes (DDM2)

NCT01736865

COMPLETED

Improving the STOP-Bang Screening Questionnaire for Patients With Sleep Apnea

NCT01610648

COMPLETED NA

Tai Chi and Aerobic Exercise for Fibromyalgia (FMEx)

NCT01420640

COMPLETED NA

Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis

NCT02107482

COMPLETED Phase 1

Evaluation of Clinical Safety of Combining Metformin With Anticancer Chemotherapy

NCT01442870

COMPLETED Phase 4

Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess

NCT01537783

TERMINATED Phase 1

Impact of Pretreatment With Metformin on Colorectal Cancer Stem Cells (CCSC) and Related Pharmacodynamic Markers

NCT01440127

COMPLETED Phase 4

Metabolic Abnormalities in HIV-infected Persons

NCT01612858

COMPLETED Phase 4

Effect of Steroid Injections in a Knee With Osteoarthritis

NCT01230424

COMPLETED NA

Tai Chi and Physical Therapy for Knee Osteoarthritis

NCT01258985

COMPLETED

Exhaled Nitric Oxide as a Biomarker of Disease Activity in Eosinophilic Esophagitis

NCT01170234

COMPLETED NA

Single-operator Ultrasound-guided IV Placement by Emergency Nurses

NCT01439113

COMPLETED Phase 3

Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial

NCT01224210

COMPLETED NA

Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis

NCT01090063

TERMINATED Phase 3

Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

NCT01014767

COMPLETED NA

Preventing Mid- and Later-Life Work Limitations

NCT01163890

COMPLETED NA

The Optimal Time to Put Laryngeal Mask Airway in the Mouth Under General Anesthesia

NCT00972491

COMPLETED Phase 4

Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip

NCT00868088

COMPLETED Phase 2

Study of Apremilast in Atopic or Contact Dermatitis

NCT00931242

COMPLETED Phase 4

Mechanism of Action Study for Psoriasis

NCT00932113

COMPLETED NA

Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder

NCT01583829

COMPLETED

Peds Metabolic Syndrome in Psoriasis

NCT00930592

COMPLETED Phase 2

Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation

NCT00871624

TERMINATED NA

Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis

NCT00868751

COMPLETED

HIV and Kidney Function Study

NCT00905151

COMPLETED Phase 1

Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma

NCT00862901

COMPLETED

Evaluating for Contact Allergies in Patients With Chronic Urticaria

NCT00868036

COMPLETED NA

Yoga in an Urban School for Children With Emotional Behavioral Disorders

NCT01305876

COMPLETED Phase 2

Fluphenazine Hydrochloride for Psoriasis

NCT00929578

COMPLETED Phase 4

Niacin and Endothelial Function in Early CKD

NCT00852969

COMPLETED Phase 3

A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families

NCT00782145

TERMINATED Phase 2

Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma

NCT01207765

COMPLETED Phase 2

Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram

NCT00562861

COMPLETED Phase 4

Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy

NCT00879060

COMPLETED Phase 1

Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes

NCT00436475

COMPLETED

A Comparison of Monosyn and Monocryl Sutures in Surgical Wounds

NCT00731913

← Previous Page 3 of 4 Next →

What is open in the Tufts Medical Center pipeline

18 recruiting of 169 indexed (11% open); 111 completed (66%).

Phase mix: 27 late (III/IV) vs 44 early (I/II) (early-phase heavy).

Top condition: Heart Failure (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Tufts Medical Center: open-pipeline peers nationwide

Peers matched on 169 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Tufts Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200 0%5%10%15%20% Total trials Recruiting share Tufts Medical CenterAstellas Pharma Global DevelopmentBausch Health AmericasSeattle Children's HospitalSumitomo Pharma AmericaHartford HospitalUConn HealthCAMC Health SystemBastyr University
Tufts Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Tufts Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 169 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this Tufts Medical Center page

169 registered trials is a research-attention snapshot, not an endorsement of Tufts Medical Center or any single study.

  • 18 of Tufts Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Heart Failure is the condition Tufts Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Tufts Medical Center pipeline card: 169 registered trials from official public datasets.Report a data error.